Member Info for Pingu777

You're paranoid NP.

Thats rich Alde! You'd have literally nothing to say if we stuck to the facts.

All the comedians are out

"Significant part"? You sure? the warrants were the significant element of todays RNS.

A reasonable observation in terms of the language used but it would seem the Prospectus is for the warrant conversions then and the anomaly is todays RNS suggesting it relates to the CLNs.

A bit like your LSE posting activity record. And hashtags being cool and used anywhere apart from X.

...PS. Since, according to you, there won’t be any more Peterhouse or SP Angel specials, I’d say he can save himself the professional fees by getting rid, unless, of course, he never got the memo?

SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Adam Cowl

Peterhouse Capital Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey, Charles Goodfellow

That way, you and your friends can keep fleecing shareholders with your very own WhatsApp specials. Maybe aim for half-price warrants this time 😆....

"The Capital Markets business of Peterhouse Capital Limited was combined with AlbR Capital Limited and operates under the new name of AlbR Capital Limited as of October 1, 2025. Therefore, while parts of Peterhouse's business have been absorbed, Peterhouse Capital itself has changed its name as part of this combination with AlbR."

Sharpen up NP. You're better than this. It would seem 'Peterhouse' is no more!

Correct - you are currently not green binned. Excellent deduction.

I have a question!

How come, if no one can possibly knows anything about you NP, how can you claim to know exactly what everyone else is doing? Investing etc.

I just don't see how you can play both cards.

Never stop being you Alde. I can't believe I had you blocked for so long. You make entertaining reading.

Warrants are converted to shares. Then the shares have to be sold onto the market pumpky to 'cash in'. This conversion would seem to be the warrants held by institutions (not the private consortiums) being converted which imo have already been forward sold. Which means those converted shares have now just been handed back to the brokers to settle the debt. There'll be sprinklings of PIs wanting cash Pumpky, but I dont think there's too many shares gonna be hitting the market.

The lack of trolling on here tells me the shorts that opened off the back of those warrant forward selling projects are probably well on their way to being closed out now. DaddyBear3 hinted that some shorts were staying open to see if the CLN shares would be sold onto the market once converted. (the shorts knew the warrants were already forward sold of course). As I understand it the CLN converted stock is being held.

By my calcs the shorters/manipulators working off the back of forward sold warrants are all out of ammunition now. Would that make this officially the bottom for the SP then?

A deal for CAR T will happen when it happens. Everything is moving in the right direction though. I wonder whether any prospective buyer will want CDX as well - Monoclonal antibody version of CAR T? Same indication essentially.

Made scientific tech transfer moving along - commercial production is significant imo. Once signed off and cleared with FDA patient recruitment can commence. Adult patient four and peds patient one. Cellin taking the Estonia licensing project forward. More data and fast track distribution of treatment in Europe. Adding to the pressure mounting on Big Pharma to make a move.

I'm utterly convinced its going to happen. For me, it is not if, but when. CAR T is already doing what other treatments have not. I'm sure Vlad is working hard to share the story so far. We know he's already talking to big pharma.

Also I'm very interested in CBR. Vlad's hints toward a single molecule working on multiple cancers is intriguing. Platform level stuff.

Very exciting times ahead and still chronically undervalued imo. A £50m market cap for such a broad and impressive spectrum of assets with an advancing CAR T trial with very encouraging results to date continues to astound me. It will work itself out though! All's well that ends well as they say.

There once was a legend called Vlad

Who's sciency research wasn't bad

He came at the cancer

The cheeky young dancer

And left all the shorters real sad

Oh no, more money for Hemo? Building more reserves. Whilst still owning 100% of HG CT 1. CDX. CBR. I get a warm feeling inside.

Whats next on the list for the FUD crew? Is there anything left to attack?

That sounds about right Bigbone.

Any acquisition of HG CT 1 will exceed that market cap in value at £115 per share.

Vander,

That result is with bone marrow transplant for which only 30% of patients are healthy enough to partake.

Now check the median survival without bone marrow transplant, which HG CT 1 aims to replace.

Thanks.

I agree Saint. I’d suggest that’s a fact.

But rhetorically I’m kind of suggesting too much data is signified by someone else making a bid for the item before you do. Too many people get to know how good it is. Pushing you into making a move. Hence it being too much ‘for you’. And who know’s where that line is?!

I tend to think it’s not all about patient data alone either. In my head it’s a data plus signals kinda thing.

Signals include things like fast track licensing in Europe Estonia, fast track peds approval, pivoting to a commercial CDMO, CBR and CDX progress.

To me, it eventually all combined gets too much to just ignore.

“HFH there are more who deserve pity than scorn. 🤔“

I’d suggest less scorn, more yawn!

Vlad is slowly but surely moving all the pieces into place. Personal attacks, gas lighting, trading waffle etc is all nonsense on here to distract from the behemoth that soon with be Hemogenyx.

“More data, more data, more data!” Was the cry! But when does ‘more data’ become too much data?

If only we had a timeline on a week to week basis HEMO would be so much better and their assets worth considerably more.

All those fake indications of progress and success mean nothing. Daft things like:-

- tech transfer to commercial manufacturing (mass production channel being secured for HG CT 1 that doesn't really work, all pointless)

- DSMB sign off to escalate dose (de-risks program but doesn't mean anything cos we don't know if it works, its just safe)

- MD Anderson approached HEMO to run the HG CT 1 trial from their hospital (even though they're the worlds best, doesn't mean anything cos HG CT 1 doesn't work)

- Have £2mill in the bank and will collect more capital from warrant conversions (no one interested though, doesn't work)

- All patient data to date confirms the treatment is working and is safe (but it could be just luck that p1 was alive after 6 months and p3 MRD- within the month.

- paediatric expansion approved by FDA after only 2 patients safety data (its only safe, no one cares if it works and being safe is so easy for CAR T, they all pass safety)

- Cellin see merit in obtaining HG CT 1 in Estonia to treat r/r AML over there and become a gateway for European patients needing treatment - but not because it works, just because its safe)

But none of that counts. Vlad should be focused on more important things like timelines. (YAWN).

Project projection in full flight.

Have a good day.

Man who says you can’t talk about his investment position, because you know nothing of his investment position, talks about other people’s investment position he knows nothing about.